Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases

• Published in: Respiratory research Vol. 17; no. 1; p. 92
• Main Authors: Ostridge, Kristoffer, Williams, Nicholas, Kim, Viktoriya, Harden, Stephen, Bourne, Simon, Coombs, Ngaire A., Elkington, Paul T., Estepar, Raul San Jose, Washko, George, Staples, Karl J., Wilkinson, Tom M. A.
• Format: Journal Article
• Language: English
• Published: London BioMed Central 26.07.2016; BioMed Central Ltd; Nature Publishing Group
• Subjects: Aged; Airway Obstruction - diagnostic imaging; Airway Obstruction - etiology; Bronchoalveolar Lavage Fluid - chemistry; Bronchoscopy; Care and treatment; CT imaging; Emphysema, Pulmonary; Female; Health aspects; Humans; Lung - enzymology; Male; Matrix Metalloproteinase Inhibitors - pharmacology; Matrix Metalloproteinases - metabolism; Medicine; Medicine & Public Health; Middle Aged; Physiological aspects; Pneumology/Respiratory System; Pulmonary Disease, Chronic Obstructive - diagnostic imaging; Pulmonary Disease, Chronic Obstructive - enzymology; Pulmonary Emphysema - diagnostic imaging; Pulmonary Emphysema - enzymology; Respiratory function; Respiratory Function Tests; Smoking - adverse effects; Tissue Inhibitor of Metalloproteinase-1 - metabolism; Tomography, X-Ray Computed; CT; Emphysema; Imaging; MMPs; COPD
• ISSN: 1465-993X; 1465-9921; 1465-993X
• DOI: 10.1186/s12931-016-0402-z

Background Emphysema is characterised by distinct pathological sub-types, but little is known about the divergent underlying aetiology. Matrix-metalloproteinases (MMPs) are proteolytic enzymes that can degrade the extracellular matrix and have been identified as potentially important in the development of emphysema. However, the relationship between MMPs and emphysema sub-type is unknown. We investigated the role of MMPs and their inhibitors in the development of emphysema sub-types by quantifying levels and determining relationships with these sub-types in mild-moderate COPD patients and ex/current smokers with preserved lung function. Methods Twenty-four mild-moderate COPD and 8 ex/current smokers with preserved lung function underwent high resolution CT and distinct emphysema sub-types were quantified using novel local histogram-based assessment of lung density. We analysed levels of MMPs and tissue inhibitors of MMPs (TIMPs) in bronchoalveolar lavage (BAL) and assessed their relationship with these emphysema sub-types. Results The most prevalent emphysema subtypes in COPD subjects were mild and moderate centrilobular (CLE) emphysema, while only small amounts of severe centrilobular emphysema, paraseptal emphysema (PSE) and panlobular emphysema (PLE) were present. MMP-3, and -10 associated with all emphysema sub-types other than mild CLE, while MMP-7 and -8 had associations with moderate and severe CLE and PSE. MMP-9 also had associations with moderate CLE and paraseptal emphysema. Mild CLE occurred in substantial quantities irrespective of whether airflow obstruction was present and did not show any associations with MMPs. Conclusion Multiple MMPs are directly associated with emphysema sub-types identified by CT imaging, apart from mild CLE. This suggests that MMPs play a significant role in the tissue destruction seen in the more severe sub-types of emphysema, whereas early emphysematous change may be driven by a different mechanism. Trial registration Trial registration number NCT01701869 .